HWP
WST icon

Highline Wealth Partners’s West Pharmaceutical WST Stock Holding History

Highline Wealth Partners’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.51K Buy
+7
New +$2.14K ﹤0.01% 1136
2025
Q1 		– Sell
-3
Closed -$983 – 1055
2024
Q4 		$983 Buy
+3
New +$944 ﹤0.01% 532

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
GWI
Grace & White Inc Ny, New York $632M AUM 34.34% 1-Year Est. Return
MCG
McCollum Christoferson Group Amherst, New York $341M AUM 15.01% 1-Year Est. Return
YCM
Yousif Capital Management Bloomfield Hills, Michigan $8.94B AUM 42.6% 1-Year Est. Return
BZWA
Blue Zone Wealth Advisors Los Angeles, California $573M AUM 22.86% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Highline Wealth Partners's WST Position: Q2 2026 in Review

Highline Wealth Partners opened a new position in West Pharmaceutical (WST) in Q2 2026: 7 shares worth $2.51K. The stake represents ﹤0.01% of the portfolio and ranks #1136 among its holdings. This is a return to the name: Highline Wealth Partners previously reported a position in WST as recently as Q4 2024.

Highline Wealth Partners first reported a position in WST in Q4 2024 and has held it in 2 quarters since. 122 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Highline Wealth Partners held 7 shares of West Pharmaceutical worth $2.51K as of Q2 2026.
  • West Pharmaceutical was a new Highline Wealth Partners position in Q2 2026.
  • West Pharmaceutical made up ﹤0.01% of Highline Wealth Partners's portfolio in Q2 2026, its #1136 holding.
  • Highline Wealth Partners first reported a position in West Pharmaceutical in Q4 2024 and has held it in 2 quarters since.
  • 122 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Highline Wealth Partners's 13F filing for Q2 2026, filed 15 Jul 2026.